Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy
Hangping Yao(First Affiliated Hospital Zhejiang University), Ming‐Hai Wang(Texas Tech University), Chen-Yu Hu(Peking University), Linghui Chen(Zhejiang University), Sreedhar Reddy Suthe(Texas Tech University), Song Cheol Kim(Ulsan College), Weilin Wang(Zhejiang University), Zhigang Wu(Jinggangshan University), Liang Feng(Texas Tech University), Tian-Hao Weng(Wenzhou Medical University), Eun Sung Jun(Asan Medical Center), Xiangmin Tong(Westlake University)
Cited by 19
Related Papers
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Application of metagenomics in the human gut microbiome
|World Journal of Gastroenterology|2015|406
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299
A 3D-printed local drug delivery patch for pancreatic cancer growth suppression
|Journal of Controlled Release|2016|260